To read more on this topic click here.
New machine learning model could help pinpoint stages of Parkinson’s
News
Author: Sophie BatesPublished: 13 August 2020
Prep:
Cook:
Serves:

A new machine learning model aims to help clinicians understand how Parkinson’s progresses in an individual, in relation to the emergence of symptoms of the condition.
The model, designed by US technology company IBM in collaboration with US charity The Michael J Fox Foundation (MJFF), assesses how advanced an individual’s Parkinson’s is – and takes into consideration how medication may mask visible symptoms such as tremors. Researchers at IBM plan to train the model using data from people with Parkinson’s, collected by MJFF, to help define each stage of the condition.
Kristen Severson, a postdoctoral researcher at IBM Research said: “In the future, progression models such as ours may help support various clinical applications. For example, once the disease states are learned, clinicians could quantitatively group patients as well as better predict progression – which could potentially help to inform more personalised patient care and management, as well as more effective drug trials.”
For more information on the latest Parkinson’s research please visit the Parkinson’s Europe website.
Read more:
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
US hospital initiative improves on-time administration of Parkinson’s medication
Last Month
Next Month
Share this story
Related articles

Interviews
Parkinson’s and end-of-life: “I’m not afraid of dying”
Eleonor Högström on end-of-life preparations
READ MORE
Global update
How does the impact of DBS vary across Parkinson’s disease subtypes?
Exploring the treatment’s effect on non-motor symptoms
READ MORE
Advances
Fast-acting inhalable levodopa produces positive results in clinical trial
Is inhalable levodopa for treating Parkinson’s one step closer?
READ MORE
Comments